Apellis Pharmaceuticals, Inc. (BIT:1APLS)
Italy · Delayed Price · Currency is EUR 19.01
0.00 (0.00%)
At close: Oct 10, 2025
Apellis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -228.17 | -197.88 | -528.63 | -652.17 | -746.35 | -344.87 | Upgrade |
Depreciation & Amortization | 1.8 | 1.8 | 1.78 | 1.55 | 1.49 | 0.86 | Upgrade |
Stock-Based Compensation | 108.36 | 114.13 | 105.95 | 91.09 | 70.67 | 45.38 | Upgrade |
Other Adjustments | 2.45 | 12.44 | 26.41 | 61.55 | 204.59 | 118.57 | Upgrade |
Change in Receivables | 90.3 | -58.48 | -198.72 | 2.38 | -10.1 | - | Upgrade |
Changes in Inventories | 6.67 | -10.76 | -60.65 | -69.4 | -16.32 | - | Upgrade |
Changes in Accounts Payable | 16 | 1.09 | 0.17 | 18.69 | 10.49 | -0.05 | Upgrade |
Changes in Accrued Expenses | 15.19 | 18.15 | 34.95 | -6.31 | -10.39 | 55.05 | Upgrade |
Changes in Other Operating Activities | -6.19 | 31.64 | 23.99 | 38.88 | -67.2 | -35.41 | Upgrade |
Operating Cash Flow | 4.49 | -87.87 | -594.74 | -513.75 | -563.13 | -160.49 | Upgrade |
Capital Expenditures | - | -0.4 | -0.77 | -1.52 | -1.1 | -5.42 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 0.1 | - | - | - | Upgrade |
Purchases of Investments | - | - | - | -331.86 | -171.28 | -879.07 | Upgrade |
Proceeds from Sale of Investments | - | - | - | 393.28 | 420 | 567.5 | Upgrade |
Investing Cash Flow | - | -0.4 | -0.67 | 59.89 | 247.62 | -316.99 | Upgrade |
Short-Term Debt Issued | - | 365.45 | - | - | - | - | Upgrade |
Net Short-Term Debt Issued (Repaid) | - | 365.45 | - | - | - | - | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 322.87 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | - | 322.87 | Upgrade |
Issuance of Common Stock | 7.53 | 18.83 | 461.04 | 405.84 | 398.02 | 392.42 | Upgrade |
Repurchase of Common Stock | - | -0.06 | -11.04 | -5.68 | -1.79 | - | Upgrade |
Net Common Stock Issued (Repurchased) | 7.53 | 18.77 | 450 | 400.16 | 396.24 | 392.42 | Upgrade |
Other Financing Activities | - | -234.98 | -55.5 | -34.5 | -4 | -23.11 | Upgrade |
Financing Cash Flow | 5.37 | 149.24 | 394.5 | 365.66 | 392.24 | 692.18 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.25 | -0.66 | 0.14 | -0.49 | -2.02 | 0.36 | Upgrade |
Net Cash Flow | 10.04 | 60.31 | -200.78 | -88.68 | 74.71 | 215.06 | Upgrade |
Beginning Cash & Cash Equivalents | 361.43 | 352.3 | 553.07 | 641.76 | 567.05 | 351.99 | Upgrade |
Ending Cash & Cash Equivalents | 371.47 | 412.61 | 352.3 | 553.07 | 641.76 | 567.05 | Upgrade |
Free Cash Flow | 4.49 | -88.27 | -595.51 | -515.27 | -564.23 | -165.91 | Upgrade |
FCF Margin | 0.60% | -11.30% | -150.16% | -683.18% | -847.66% | -66.19% | Upgrade |
Free Cash Flow Per Share | 0.04 | -0.71 | -5.02 | -4.86 | -6.68 | -2.21 | Upgrade |
Levered Free Cash Flow | -194.72 | 209.1 | -529.15 | -670.28 | -829.38 | -6.98 | Upgrade |
Unlevered Free Cash Flow | -158.02 | -124.43 | -519.74 | -613.33 | -619.56 | -199.85 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.